| PERIOD ENDING | 24-Oct-09 | 25-Jul-09 | 25-Apr-09 | 24-Jan-09 | | Total Revenue | 404,089 | 398,928 | 375,709 | 343,201 | | Cost of Revenue | 240,292 | 237,994 | 220,642 | 230,516 | | | Gross Profit | 163,797 | 160,934 | 155,067 | 112,685 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 113,771 | 113,640 | 103,057 | 102,987 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 12,211 | 12,505 | 11,715 | 12,111 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 37,815 | 34,789 | 40,295 | (2,413) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,262 | 1,377 | 750 | 1,874 | | Earnings Before Interest And Taxes | 39,077 | 36,166 | 41,045 | (539) | | Interest Expense | 2,560 | 1,175 | 1,208 | 1,186 | | Income Before Tax | 36,517 | 34,991 | 39,837 | (1,725) | | Income Tax Expense | 14,845 | 8,570 | 15,986 | (657) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 21,672 | 26,421 | 23,851 | (1,068) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,672 | 26,421 | 23,851 | (1,068) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $21,672 | $26,421 | $23,851 | ($1,068) |
|
0.51% Nasdaq 
Income Statement
